be given Viracept at this time. Pregnant women who are currently receiving Viracept should be switched to an alternative antiretroviral therapy, if possible. But if a pregnant patient has no alternative treatment options, the benefits of continuing to use Viracept are considered to outweigh the risks. Additional Information: FDA MedWatch Safety Alert. Viracept (nelfinavir mesylate). September 10, 2007. www.fda.gov … Viracept Children HIV AIDS Pregnant Women Nelfinavir Mesylate Drug …
Tweet This Post
Infectious Diseases in Abkhazia Pose Threat to Regional and Global Health Separatist government policies in Abkhazia (that restrict public health and humanitarian aid have created an environment where AIDS, drug-resistant tuberculosis, malaria and bird flu (H5N1) are spreading unchecked Ramaz Mitaishvili, MD Irakli Gagua Ushangi Rezhinashvili, PhD www.abkhazia.com http … Abkhazia Georgia Russia Armenia health WHO Tuberculosis malaria AIDS drug
The story of this patient in Lagos, Nigeria reinforces the realities of treating HIV/AIDS in Nigeria. … msf kaletra nigeria aids hiv
Powered by Yahoo! Answers
Search engine optimization by SEO Design Solutions